Sign in
PLSE Stock Price, Chart, Stats & News
Pulse Biosciences, Inc.
Save
1.86B
Market cap
–
Current P/E
–
Forward P/E
PLSE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -204.29% |
Operating margin | -21982.57% |
Pretax margin | -20794.57% |
Net margin | -20794.57% |
Effective tax rate | – |
ROA | -75.72% |
ROE | -73.46% |
D/E | 0.09x |
Interest coverage ratio | – |
PLSE valuation
P/E | – |
P/S | 3995.82x |
P/B | 17.19x |
P/CF | -25.61x |
P/FCF | -25.69x |
P/OCF | -25.61x |
PEG | -3.13x |
EV multiple | -20.17x |
About
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses.
Similar securities
Based on sector and market capitalization
Report issue